Thirteen beautiful men and women raise awareness about an ugly topic: colorectal cancer. These sexy survivors are showing their scars hoping to save lives.

Picking the right drugs to treat colon cancer may depend on the type of KRAS genes in the tumor. Experts are now saying advance testing is the way to go.

Researchers from Wake Forest University have completed a Phase I study that may help improve the survival rate for patients with appendix cancer or colorectal cancer that’s spread to their abdomen.
Wake Forest’s study identified the maximum amount of a chemotherapy drug peritoneal cancer patients can successfully tolerate during Intraperitoneal Hyperthermic Chemotherapy (IPHC) treatments following [...]

Representatives from five major US cancer care groups have collaborated to create new colorectal cancer screening guidelines designed to detect precancerous adenomas and malignant tumors in patients showing no symptoms.
The American Cancer Society, the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy and the American College of Radiology weighed [...]

Research conducted by the John Wayne Cancer Institute (JWCI) at Saint John’s Health Center indicates the receptor protein CCR9 may promote the spread of melanoma to the small intestine.
Unlike other cancers, melanoma skin cancer commonly metastasizes to the lower bowel and, until recently, scientists were at a loss to explain the connection. JWCI’s [...]

Patients being treated for metastatic colorectal cancer in Europe just got a new treatment option.
Capecitabine, which is marketed by Switzerland-based pharmaceutical company Roche under the trade name Xeloda, has been approved by the European Commission for the treatment of metastatic colorectal cancer.
European health officials approved the oral tablets for use in combination with any chemotherapy [...]

Effective April 1, 2008, Aetna (NYSE: AET) will no longer cover an anesthetic commonly used during colonoscopies, a diagnostic tool used to detect colorectal cancer. Similar exclusions have already been implemented by WellPoint (NYSE: WLP) and Humana (NYSE: HUM).
The drug propofol, marketed under the trade name Diprivan, is used to thoroughly [...]

Scientists from the Massachusetts General Hospital (MGH) BioMicroMechanical Systems (BioMEMS) Resource Center and the MGH Cancer Center have developed a new microchip-based device that can isolate circulating tumor cells (CTC) in a blood sample.
The new CTC-chip is a business-card sized silicon chip covered with almost 80,000 microscopic posts smaller than a human hair. [...]

Research conducted by the University of Minnesota shows women with diabetes are 50 percent more likely to develop colorectal cancer than non-diabetic women.
To perform their study, the team analyzed data on over 45,000 women who participated in a large-scale breast cancer study conducted at 29 medical facilities during the 1970s. The records indicated females [...]

Results of a Swedish study published in the November 2007 issue of The Lancet Oncology show children of parents who survived certain cancers are more likely to survive the disease if it strikes them too.
To arrive at their conclusion, researchers from the Karolinska Institutet and Stockholm Söder Hospital, studied data on over three [...]